Systemic Enzyme Therapy in Oncology
- 作者Dr Jörg Leipner, Reinhard Saller
- 卷第59卷
- 期第4期
- 文件大小228.38KB
- 发表时间2000-04
- DOI10.2165/00003495-200059040-00004
- 页码769-780
Oral topotecan [`Hycamtin'] is as effective as IV topotecan2001
Weekly Topotecan: An Alternative to Topotecan's Standard Daily x 5 Schedule?Rowinsky, E. K. · The Oncologist · 2002
Topotecan Continuous Infusion: CA-125 Responses Including Patients Pretreated with Other Schedules of TopotecanMuggia, F. · The Oncologist · 2006
Topotecan (Hycamptin) and Topotecan-Containing Regimens in the Treatment of Hematologic MalignanciesMILOSLAV BERAN; HAGOP M. KANTARJIAN · 2000
Using plasma topotecan pharmacokinetics to estimate topotecan exposure in cerebrospinal fluid of children with medulloblastomaFreeman, B. B. · Neuro-Oncology · 2006
Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel.Miller, A A; Lilenbaum, R C; Lynch, T J; Rosner, G L; Ratain, M J; Green, M R; Schilsky, R L · Journal of Clinical Oncology · 1996
Comparative Activity of Oral and Parenteral Topotecan in Murine Tumor Models: Efficacy of Oral TopotecanMcCabe, Francis L.; Johnson, Randall K. · Cancer Investigation · 1994
Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damageFriederike Schmidt; Johannes Rieger; Jörg Wischhusen; Ulrike Naumann; Michael Weller · 2001